IP Library Patent Application 12487869
Patent Application
App. No. 12/487,869

Genes that are Up- or Down-Regulated During Differentiation of Human Embryonic Stem Cells

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/487,869
Abstract

Genes that are up- or down-regulated during differentiation provide important leverage by which to characterize and manipulate early-stage pluripotent stem cells. Over 35,000 unique transcripts have been amplified and sequenced from undifferentiated human embryonic stem cells, and three types of differentiated progeny. Statistical analysis of the assembled transcripts identified genes that alter expression levels as differentiation proceeds. The expression profile provides a marker system that has been used to identify particular culture components for maintaining the undifferentiated phenotype. The gene products can also be used to promote differentiation; to assess other relatively undifferentiated cells (such as cancer cells); to control gene expression; or to separate cells having desirable characteristics. Manipulation of particular genes can be used to forestall or focus the differentiation process, en route to producing a specialized homogenous cell population suitable for human therapy.

Claims (7)

1 - 48 . (canceled)

49 . A method of separating an undifferentiated cell from a mixed population of cells comprising contacting the mixed population of cells with a ligand to a marker expressed by the undifferentiated cells chosen from solute carrier family member 16, and solute carrier family member 7.

50 . The method of claim 49 , wherein the marker expressed by the undifferentiated cell is solute carrier family member 16.

51 . The method of claim 49 , wherein the marker expressed by the undifferentiated cell is solute carrier family member 7.

52 . The method of claim 49 , wherein the ligand is an antibody.

53 . A method of separating a differentiated cell from a mixed population of cells comprising contacting the mixed population of cells with a ligand to neuronal pentraxin receptor.

54 . The method of claim 53 , wherein the ligand is an antibody.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2013
From: GERON CORPORATION
To: ASTERIAS BIOTHERAPEUTICS, INC.
Reel/Frame 031620/0567 →